Malnutrition in Cirrhosis: Frequent but Overlooked
Gabriela Kuftinec, Kalyan Ram Bhamidimarri, Michelle Pearlman – 14 October 2019
Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West
Hansen Dang, Yee Hui Yeo, Satoshi Yasuda, Chung‐Feng Huang, Etsuko Iio, Charles Landis, Dae Won Jun, Masaru Enomoto, Eiichi Ogawa, Pei‐Chien Tsai, An Le, Matthew Liu, Mayumi Maeda, Brian Nguyen, Nathan Ramrakhiani, Linda Henry, Ramsey Cheung, Akihiro Tamori, Takashi Kumada, Yasuhito Tanaka, Ming‐Lung Yu, Hidenori Toyoda, Mindie H. Nguyen – 14 October 2019
Reply:
Zhao‐Ning Lu, Ze‐Guang Han – 14 October 2019
Changing Etiologies and Prognostic Factors in Pediatric Acute Liver Failure
Manuel Mendizabal, Marcelo Dip, Ezequiel Demirdjian, Leandro Lauferman, Susana Lopez, Julia Minetto, Alejandro Costaguta, Carolina Rumbo, Ivone Malla, María Camila Sanchez, Esteban Halac, Guillermo Cervio, Miriam Cuarterolo, Marcela Galoppo, Oscar Imventarza, Liliana Bisgniano, Daniel D’Agostino, Fernando Rubinstein – 13 October 2019 – After the implementation of universal hepatitis A virus vaccination in Argentina, the outcome of pediatric acute liver failure (PALF) remains unknown.
Everolimus: Longer‐Term CERTITUDE
Omar Y. Mousa, Andrew P. Keaveny – 13 October 2019
Tuberculosis Treatment With a 3‐Drug Rifamycin‐Free Regimen in Liver Transplant Recipients
Timothy Sullivan, Samantha Jacobs, Jennifer Leong, Dallas Dunn, Emily Baneman, Sarah Taimur, Shirish Huprikar, Meenakshi Rana – 13 October 2019
Advanced Practice Providers: Raising Our Defenses Against the Rising Tide of Cirrhosis
Ashley M. Hyde, Michelle Carbonneau, Juan G. Abraldes, Puneeta Tandon – 12 October 2019
Novel Arterial Reconstruction With Donor Femoral Artery in Split‐Liver Transplantation
Flavio Paterno, Lloyd Brown, Dorian Wilson, Nikolaos Pyrsopoulos, James V. Guarrera – 12 October 2019
qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis
Feng Liu, George Boon‐Bee Goh, Dina Tiniakos, Aileen Wee, Wei‐Qiang Leow, Jing‐Min Zhao, Hui‐Ying Rao, Xiao‐Xiao Wang, Qin Wang, Wei‐Keat Wan, Kiat‐Hon Lim, Manuel Romero‐Gomez, Salvatore Petta, Elisabetta Bugianesi, Chee‐Kiat Tan, Stephen A. Harrison, Quentin M. Anstee, Pik‐Eu Jason Chang, Lai Wei – 10 October 2019
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
Anna S. Lok, Fabien Zoulim, Geoffrey Dusheiko, Henry L.Y. Chan, Maria Buti, Marc G. Ghany, Anuj Gaggar, Jenny C. Yang, George Wu, John F. Flaherty, G. Mani Subramanian, Stephen Locarnini, Patrick Marcellin – 10 October 2019 – In patients with chronic hepatitis B (CHB), loss of hepatitis B surface antigen (HBsAg) is considered a functional cure. However, HBsAg loss is uncommon with existing therapies, and predictive factors associated with HBsAg seroreversion are unknown.